The dermatology company has opened the doors of its new U.S. headquarters in Miami, Florida, positioning the company at the heart of a thriving market for dermatological skincare and injectable aesthetics.

Galderma expects the new facility, located in the Brickell neighborhood, to gather approximately 150 employees, including U.S. leadership roles, by 2028.

Over the last decade, Miami has emerged has a premium market and destination for consumer skincare, consumer health, and aesthetic treatments.

"The city’s emergence as a premium destination and a trend-setter in areas closely aligned to our activities, as well as its fast-growing healthcare professional community, makes Miami a natural choice for our U.S. headquarters. Being in Miami will enrich our business with top talent that will prove invaluable to our future success," said Flemming Ørnskov, Galderma’s Chief Executive Officer.

The Miami metro area boasts one of the highest concentrations of medical spas and dermatological aesthetic clinics in the United States, with aesthetic procedures growing at an estimated 30% year-over-year. It also hosts the nation’s second-largest medical district, the Miami Health District, with numerous hospitals and research facilities.

In addition to its new headquarters in Miami, Galderma will maintain a strong presence across several U.S. locations. Boston, MA, will remain the hub for the company’s U.S. Therapeutic Dermatology business and U.S. Research and Development organization. Carlsbad, CA, will continue as a hub for Alastin, the company’s premium, physician-dispensed skincare brand. The Dallas, TX, office will continue as one of Galderma’s key U.S. sites while the company’s North America distribution center will remain in Fort Worth, TX.

In addition, Galderma has announced the appointment of Heather Wallace as President of Galderma U.S., based in Miami. Before joining Galderma, Ms Wallace served as Chief Executive Officer of Curology, a leader in personalized prescription skincare, and as President of the Americas region for Revlon, where she oversaw strategic and cultural transformation efforts to maximize profitability in the company’s largest region.

In Dermatological Skincare, Galderma is best known for Cetaphil, a leading dermatologist recommended brand for sensitive skin with more than 70-year heritage in the United States. Galderma’s premium portfolio also includes the physician-dispensed skincare brand Alastin, a leader in medical-grade peptide-based regenerative skincare.

Last year, French cosmetics giant L’Oréal took a 10% share in Galderma and inked a scientific partnership with the aim to “accelerate innovation in the field of dermatology,” in particular to fight the “signs of skin aging.”